iCancerhealth Platform Now Available for Testicular Cancer Patients and Caregivers
CINCINNIATI, OH (PRWEB) – The Testicular Cancer Society (TCS) has partnered with Medocity, Inc. to provide a new layer of patient and caregiver support. Beginning April 2016, TCS patients and their families will have free access to the iCancerHealth platform where they will be able to access TCS support information while using iCancerHealth to coordinate care and track symptoms, medications and more.
iCancerHealth is an intuitive, comprehensive platform that bridges the gap between the clinic and the patient’s home. Key features include:
- Ability to manage and track medications and symptoms;
- Guiding the patient and caregiver with timely disease and drug specific information; and
- Connecting the patient with the patient’s care team, family and friends to share information.
“When diagnosed, testicular cancer suddenly becomes a whole new world,” said Mike Craycraft, survivor and founder of the Testicular Cancer Society. “We are pleased to add the iCancerHealth platform to help offer our resources and end the isolation so often seen with patients and their families. The mobile and web platform will allow those diagnosed to become more educated and better self advocates of their care.”
“Medocity is looking forward to providing users with information and support provided by the Testicular Cancer Society,” said Raj Agarwal, CEO and president of Medocity. “The new partnership will further Medocity’s goals of providing e-support tools to patients, allowing them to manage their care needs while away or at home.”
To learn more about the partnership, or for help, call the Testicular Cancer Society at 513-696-9827 or visit http://www.TesticularCancerSociety.org
View the Original Press Release: http://www.prweb.com/releases/2016/04/prweb13304717.htm
About Testicular Cancer Society
Testicular Cancer Society is a 501(c)3 nonprofit charity that reduces the burden of testicular cancer by increasing education and awareness and providing support services to fighters, survivors and caregivers.
Medocity, headquartered in Parsippany, New Jersey, is a recognized leader in comprehensive virtual care products and services including chronic condition management, televisits, and remote patient monitoring. Our unique, innovative technology combines multiple telehealth capabilities onto a single, integrated care coordination and management platform, along with robust clinical intelligence including rules-based algorithms, alerts and decision support tools to help drive earlier detection and proactive interventions.
The Medocity platform is specifically designed to enable and improve patient-centered care delivered outside the hospital setting, particularly for patients at home who have chronic conditions responsible for more than 80% of the nation’s annual healthcare spend. By promoting patient-clinician engagement through shared connectivity and virtual technology, we enable rich, real-time interactions between patients, clinicians, care professionals and support teams.
Our vision is to dramatically improve care at lower cost for patients when they need it the most – when they’re at home, on their own, or in between visits with their care providers. Virtually. (http://www.medocity.com)